Which patients with aortic stenosis should be referred to surgery rather than transcatheter aortic valve implantation?

S Windecker, T Okuno, A Unbehaun… - European heart …, 2022 - academic.oup.com
Transcatheter aortic valve implantation (TAVI) has matured into a standard treatment option
for patients with severe symptomatic aortic valve stenosis (AS) across the whole spectrum of …

Management of patients with aortic valve stenosis

A Kanwar, JJ Thaden, VT Nkomo - Mayo Clinic Proceedings, 2018 - Elsevier
With increased life expectancy and aging of the population, aortic stenosis is now one of the
most common valvular heart diseases. Early recognition and management of aortic stenosis …

The BASILICA trial: prospective multicenter investigation of intentional leaflet laceration to prevent TAVR coronary obstruction

JM Khan, AB Greenbaum, VC Babaliaros… - JACC: Cardiovascular …, 2019 - jacc.org
Abstract Objectives: The BASILICA (Bioprosthetic or native Aortic Scallop Intentional
Laceration to prevent Iatrogenic Coronary Artery obstruction during TAVR) investigational …

Repeat transcatheter aortic valve replacement for transcatheter prosthesis dysfunction

U Landes, JG Webb, O De Backer… - Journal of the American …, 2020 - jacc.org
Background Transcatheter aortic valve replacement (TAVR) use is increasing in patients
with longer life expectancy, yet robust data on the durability of transcatheter heart valves …

Long-term outcomes after transcatheter aortic valve implantation in failed bioprosthetic valves

S Bleiziffer, M Simonato, JG Webb… - European heart …, 2020 - academic.oup.com
Aims Due to bioprosthetic valve degeneration, aortic valve-in-valve (ViV) procedures are
increasingly performed. There are no data on long-term outcomes after aortic ViV. Our aim …

Transcatheter laceration of aortic leaflets to prevent coronary obstruction during transcatheter aortic valve replacement: concept to first-in-human

JM Khan, D Dvir, AB Greenbaum, VC Babaliaros… - JACC: Cardiovascular …, 2018 - jacc.org
Objectives: This study sought to develop a novel technique called bioprosthetic or native
aortic scallop intentional laceration to prevent coronary artery obstruction (BASILICA) …

Transcatheter aortic valve replacement of failed surgically implanted bioprostheses: the STS/ACC registry

EM Tuzcu, SR Kapadia, S Vemulapalli… - Journal of the American …, 2018 - jacc.org
Abstract Background: Valve-in-valve (ViV) transcatheter aortic valve replacement (TAVR)
has been shown to be feasible, yet the safety and efficacy in relation to native valve (NV) …

Transcatheter valve-in-valve aortic valve replacement as an alternative to surgical re-replacement

P Deharo, A Bisson, J Herbert, T Lacour… - Journal of the American …, 2020 - jacc.org
Background Valve-in-valve (VIV) transcatheter aortic valve replacement (TAVR) and redo
surgical aortic valve replacement (SAVR) represent the 2 treatments for aortic bioprosthesis …

3-year outcomes after valve-in-valve transcatheter aortic valve replacement for degenerated bioprostheses: the PARTNER 2 registry

JG Webb, DJ Murdoch, MC Alu, A Cheung… - Journal of the American …, 2019 - jacc.org
Background: Transcatheter aortic valve replacement (TAVR) for degenerated surgical
bioprosthetic aortic valves is associated with favorable early outcomes. However, little is …

2019 Canadian Cardiovascular Society position statement for transcatheter aortic valve implantation

AW Asgar, M Ouzounian, C Adams, J Afilalo… - Canadian Journal of …, 2019 - Elsevier
Transcatheter aortic valve implantation (TAVI) or replacement has rapidly changed the
treatment of patients with severe symptomatic aortic stenosis. It is now the standard of care …